Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)
Clinical trial NCT07055880 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07055880
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-28
- Primary completion
- 2026-01-15
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.